US equities |
NVDA $168.89 ▲+0.00% MU $725.11 ▲+0.00% AMD $515.21 ▲+0.00% SNDK $859.99 ▲+0.00% SPCX $143.09 ▲+0.00% CRWV $48.73 ▲+0.00% NBIS $134.00 ▲+0.00% INTC $58.13 ▲+0.00%
FinancialContent

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

9.260 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Harvard Bioscience Announces Third Quarter 2026 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Creation of Scientific Advisory Board
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Second Quarter 2026 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Sidoti Events, LLC's May Micro-Cap Virtual Conference
Via ACCESS Newswire
News headline image
Harvard Bioscience Announces First Quarter 2026 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in Upcoming Investor Conferences
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Reverse Stock Split
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Third Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Specificity (OTCQB: SPTY) Signs LOI with Blackpearl – Global Push to End $250B Ad Tech Fraud – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Fraud
News headline image
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
- Strategic expansion with trusted partner enhances customer reach 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
Veteran life sciences industry financing leader appointed as new Board member 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Second Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Appoints John Duke to Board of Directors
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces First Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces CFO Transition
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >